Bartter syndrome: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 16: | Line 16: | ||
'''For patient information click [[{{PAGENAME}} (patient information)|here]]''' | '''For patient information click [[{{PAGENAME}} (patient information)|here]]''' | ||
{{ | {{CMG}} | ||
{{SK}} Hyperprostaglandin E syndrome; juxtaglomerular hyperplasia with secondary aldosteronism; Barter disease; Barter's disease; Bartter disease; Bartter's disease | |||
==[[Bartter syndrome overview|Overview]]== | ==[[Bartter syndrome overview|Overview]]== | ||
Revision as of 20:39, 30 September 2012
| Bartter syndrome | |
| ICD-10 | E26.8 |
|---|---|
| ICD-9 | 255.13 |
| OMIM | 601678 241200 607364 602522 |
| DiseasesDB | 1254 |
| MeSH | D001477 |
|
Bartter syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Bartter syndrome On the Web |
|
American Roentgen Ray Society Images of Bartter syndrome |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Hyperprostaglandin E syndrome; juxtaglomerular hyperplasia with secondary aldosteronism; Barter disease; Barter's disease; Bartter disease; Bartter's disease
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Bartter syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Cost-Effectiveness of Therapy | Future or Investigational Therapies